Capstone Investment Advisors
TAK icon

Capstone Investment Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Capstone Investment Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-270,000
Closed -$4.54M – 1365
2018
Q4 		$4.54M Buy
+270,000
New +$4.56M 0.06% 264

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Capstone Investment Advisors's TAK Position: Q3 2024 in Review

Capstone Investment Advisors sold out of Takeda Pharmaceutical (TAK) in Q3 2024, closing a stake of 40,162 shares — an estimated $520K sold.

Capstone Investment Advisors first reported a position in TAK in Q2 2023 and held it in 3 quarters. The position peaked at $520K in Q2 2024. 299 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

  • Capstone Investment Advisors reported no remaining Takeda Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 40,162 Takeda Pharmaceutical shares in Q3 2024, an estimated $520K.
  • Capstone Investment Advisors first reported a position in Takeda Pharmaceutical in Q2 2023 and held it in 3 quarters.
  • Capstone Investment Advisors's Takeda Pharmaceutical position peaked at $520K in Q2 2024.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on Capstone Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.